Recent advance in nanomaterials for cancer immunotherapy

Nanomaterial Delivery Systems for mRNA Vaccines

(2021) Michael D. Buschmann et al.   Vaccines

Nanobiomaterial-based vaccination immunotherapy of cancer

(2021) Fangmin Chen et al.   BIOMATERIALS

Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy

(2021) Ping Xiao et al.   NANO LETTERS

Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy

(2021) Faisal Raza et al.   Advanced Healthcare Materials

Landscape and progress of global COVID-19 vaccine development

(2021) Hui-Yao Huang et al.   Human Vaccines & Immunotherapeutics

Advanced biomaterials for cancer immunotherapy

(2020) Fan Yang et al.   ACTA PHARMACOLOGICA SINICA

Immune Responses to Viral Gene Therapy Vectors

(2020) Jamie L. Shirley et al.   MOLECULAR THERAPY

A Fast and Sensitive Luciferase-based Assay for Antibody Engineering and Design of Chimeric Antigen Receptors

(2020) Venkatesh Natarajan et al.   Scientific Reports

Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy

(2020) Xianwu Wang et al.   ACS Central Science

Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy

(2020) Zecong Xiao et al.   Science Advances

Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma

(2020) Chandramohan Kiruthiga et al.   Cancers

RNA Origami Nanostructures for Potent and Safe Anticancer Immunotherapy

(2020) Xiaodong Qi et al.   ACS Nano

Cholesterol-modified DP7 enhances the effect of individualized cancer immunotherapy based on neoantigens

(2020) Rui Zhang et al.   BIOMATERIALS

The Emerging Landscape of Immune Cell Therapies

(2020) Evan W. Weber et al.   CELL

Controlled synthesis of polypeptides

(2020) Yang Liu et al.   CHINESE CHEMICAL LETTERS

The Current Understanding of Autophagy in Nanomaterial Toxicity and Its Implementation in Safety Assessment-Related Alternative Testing Strategies

(2020) Rong-Jane Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

PLGA Based Nanoparticles for the Monocyte-Mediated Anti-Tumor Drug Delivery System

(2020) Paola Allavena et al.   Journal of Biomedical Nanotechnology

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

(2020) Afsheen Raza et al.   Journal of Translational Medicine

Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer

(2020) Lei Zhou et al.   NANO LETTERS

Metabolic labeling and targeted modulation of dendritic cells

(2020) Hua Wang et al.   NATURE MATERIALS

Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy

(2020) Yuanlin Wu et al.   PHARMACOLOGICAL RESEARCH

Advances in engineering local drug delivery systems for cancer immunotherapy

(2020) Peter Abdou et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

(2020) Yuanyuan Zhang et al.   Cellular & Molecular Immunology

Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy

(2020) Xueguang Lu et al.   Science Translational Medicine

Black Phosphorus Nanosheet with High Thermal Conversion Efficiency for Photodynamic/Photothermal/Immunotherapy

(2020) Danyang Xu et al.   ACS Biomaterials-Science & Engineering

Progress in Biomedical Applications of Tetrahedral Framework Nucleic Acid-Based Functional Systems

(2020) Tao Zhang et al.   ACS Applied Materials & Interfaces

Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma: a new emerging treatment?

(2020) Bastiaan Sol et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Biomimetic cancer cell membrane-coated nanosystems as next-generation cancer therapies

(2020) Miguel Pereira-Silva et al.   Expert Opinion on Drug Delivery

A DNA nanodevice-based vaccine for cancer immunotherapy

(2020) Shaoli Liu et al.   NATURE MATERIALS

Poly-ICLC, a multi-functional immune modulator for treating cancer

(2020) Hussein Sultan et al.   SEMINARS IN IMMUNOLOGY

Cancer immunotherapy–related adverse events: causes and challenges

(2020) Ada G. Blidner et al.   SUPPORTIVE CARE IN CANCER

DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine

(2020) Rui Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy

(2020) Ahmet Yilmaz et al.   Journal of Hematology & Oncology

Altered NKp46 Recognition and Elimination of Influenza B Viruses

(2020) Alexandra Duev-Cohen et al.   Viruses-Basel

The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration

(2020) Lien Van Hoecke et al.   Molecular Therapy-Nucleic Acids

Centromeric KIR AA Individuals Harbor Particular KIR Alleles Conferring Beneficial NK Cell Features with Implications in Haplo-Identical Hematopoietic Stem Cell Transplantation

(2020) Léa Dubreuil et al.   Cancers

Emerging Nano-/Microapproaches for Cancer Immunotherapy

(2019) Yu Mi et al.   Advanced Science

Turning the corner on therapeutic cancer vaccines

(2019) Robert E. Hollingsworth et al.   npj Vaccines

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors

(2019) Gaurav Nayyar et al.   Frontiers in Oncology

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients

(2019) Koichi Saruwatari et al.   Cancers

miRNA‐Specific Unlocking of Drug‐Loaded Metal–Organic Framework Nanoparticles: Targeted Cytotoxicity toward Cancer Cells

(2019) Wei‐Hai Chen et al.   Small

Nanoparticle systems for cancer vaccine

(2019) Ru Wen et al.   Nanomedicine

Biocompatible and biodegradable inorganic nanostructures for nanomedicine: Silicon and black phosphorus

(2019) Meng Qiu et al.   Nano Today

A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion

(2019) Shanye Yin et al.   CANCER CELL

Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy

(2019) Wei Xie et al.   ACS Nano

Magnetic Nanoclusters Armed with Responsive PD-1 Antibody Synergistically Improved Adoptive T-Cell Therapy for Solid Tumors

(2019) Weidong Nie et al.   ACS Nano

Advances in immunotherapy delivery from implantable and injectable biomaterials

(2019) David G. Leach et al.   Acta Biomaterialia

Effects of Titanium Dioxide Nanoparticles Exposure on Human Health—a Review

(2019) Ewa Baranowska-Wójcik et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Cancer nanomedicine for combination cancer immunotherapy

(2019) Jutaek Nam et al.   Nature Reviews Materials

Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multiantigen-Associated Specific Cytotoxic T Lymphocytes: A Phase I Study

(2019) Amy B. Hont et al.   JOURNAL OF CLINICAL ONCOLOGY

Intracellularly Generated Immunological Gold Nanoparticles for Combinatorial Photothermal Therapy and Immunotherapy against Tumor

(2019) Dan Zhang et al.   NANO LETTERS

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

(2019) Matthew D. Hellmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

CAR-NK for tumor immunotherapy: Clinical transformation and future prospects

(2019) Wenxiu Wang et al.   CANCER LETTERS

Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56

(2019) Fan Zou et al.   Nature Communications

Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells

(2019) Hye Eun Lee et al.   Scientific Reports

Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells

(2019) Evelyn O. Ojo et al.   Scientific Reports

Engineered T Cell Therapy for Cancer in the Clinic

(2019) Lijun Zhao et al.   Frontiers in Immunology

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy

(2019) Haoyu Sun et al.   Frontiers in Immunology

Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

(2019) Xiao Han et al.   Science Advances

Toxicity testing in the 21st century: progress in the past decade and future perspectives

(2019) D. Krewski et al.   ARCHIVES OF TOXICOLOGY

Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses

(2019) Xiang Liu et al.   BIOMATERIALS

Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy

(2019) Sophia Stock et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Recent Progress on Stability and Passivation of Black Phosphorus

(2018) Yohannes Abate et al.   ADVANCED MATERIALS

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

(2018) Ye Li et al.   Cell Stem Cell

Oncolytic viruses and immunity

(2018) Shyambabu Chaurasiya et al.   CURRENT OPINION IN IMMUNOLOGY

Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer

(2018) Lina Liu et al.   MOLECULAR THERAPY

Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA

(2018) Rebecca L. Ball et al.   NANO LETTERS

Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy

(2018) David R. Wilson et al.   Nanomedicine-Nanotechnology Biology and Medicine

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

(2018) Nikolaos Zacharakis et al.   NATURE MEDICINE

Understanding the tumor immune microenvironment (TIME) for effective therapy

(2018) Mikhail Binnewies et al.   NATURE MEDICINE

Advanced tools for the safety assessment of nanomaterials

(2018) Bengt Fadeel et al.   Nature Nanotechnology

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

(2018) David Adams et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chimeric Antigen Receptor Therapy

(2018) Carl H. June et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

(2018) Michael A. Postow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

(2018) A. J. Davenport et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CAR-T cells: the long and winding road to solid tumors

(2018) Maria Michela D’Aloia et al.   Cell Death & Disease

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)

(2018) Young Kwang Chae et al.   Journal for ImmunoTherapy of Cancer

Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab

(2018) Andrew L Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma

(2018) Nicole A Carreau et al.   Future Oncology

Revealing molecular-level surface redox sites of controllably oxidized black phosphorus nanosheets

(2018) Puritut Nakhanivej et al.   NATURE MATERIALS

Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells

(2018) Michelle L. Saetersmoen et al.   Seminars in Immunopathology

Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals

(2018) Xiaowan Yin et al.   Frontiers in Immunology

Multiple approaches to immunotherapy - the new pillar of cancer treatment

(2017) Mark J Smyth   IMMUNOLOGY AND CELL BIOLOGY

Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival

(2017) Matteo Donadon et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

(2017) Matthew D Hellmann et al.   LANCET ONCOLOGY

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

(2017) Paolo A Ascierto et al.   LANCET ONCOLOGY

The mechanisms tumor cells utilize to evade the host's immune system

(2017) Nyanbol Kuol et al.   MATURITAS

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

(2017) Alec J. Walker et al.   MOLECULAR THERAPY

Engineering Natural Killer Cells for Cancer Immunotherapy

(2017) Katayoun Rezvani et al.   MOLECULAR THERAPY

Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4

(2017) Dohyeong Kwon et al.   NANO LETTERS

Therapeutic T cell engineering

(2017) Michel Sadelain et al.   NATURE

A STING-activating nanovaccine for cancer immunotherapy

(2017) Min Luo et al.   Nature Nanotechnology

The immune contexture in cancer prognosis and treatment

(2017) Wolf H. Fridman et al.   Nature Reviews Clinical Oncology

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome

(2017) Hashem O. Alsaab et al.   Frontiers in Pharmacology

Cancer immune contexture and immunotherapy

(2016) Etienne Becht et al.   CURRENT OPINION IN IMMUNOLOGY

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

(2016) J.M. Michot et al.   EUROPEAN JOURNAL OF CANCER

Nanostructured lipid carriers: Promising drug delivery systems for future clinics

(2016) Ana Beloqui et al.   Nanomedicine-Nanotechnology Biology and Medicine

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

(2016) Lena M. Kranz et al.   NATURE

Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future

(2016) Anna N. Ilinskaya et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Oxidative stress pathways involved in cytotoxicity and genotoxicity of titanium dioxide (TiO2) nanoparticles on cells constitutive of alveolo-capillary barrier in vitro

(2016) Maïté Hanot-Roy et al.   TOXICOLOGY IN VITRO

Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles

(2015) Srinivas Ramishetti et al.   ACS Nano

STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice

(2015) Zili Wang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer

(2015) Jenny G. Parvani et al.   CANCER RESEARCH

Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy

(2015) Xiangjiao Meng et al.   CANCER TREATMENT REVIEWS

Programmed death-1 & its ligands: promising targets for cancer immunotherapy

(2015) Rajeev K Shrimali et al.   Immunotherapy

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

(2015) Jeffrey S Weber et al.   LANCET ONCOLOGY

NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

(2015) Aaron P Rapoport et al.   NATURE MEDICINE

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

The future of immune checkpoint therapy

(2015) P. Sharma et al.   SCIENCE

Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment

(2015) Yeyejide Adeleye et al.   TOXICOLOGY

NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade

(2015) Frederick J Kohlhapp et al.   Journal for ImmunoTherapy of Cancer

Chemical Tumor-Targeting of Nanoparticles Based on Metabolic Glycoengineering and Click Chemistry

(2014) Sangmin Lee et al.   ACS Nano

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

(2014) Suzanne L. Topalian et al.   JOURNAL OF CLINICAL ONCOLOGY

Mechanisms of nanotoxicity: Generation of reactive oxygen species

(2014) Peter P. Fu et al.   JOURNAL OF FOOD AND DRUG ANALYSIS

Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy

(2014) Guiming Chen et al.   MEDICAL ONCOLOGY

MUC1: a multifaceted oncoprotein with a key role in cancer progression

(2014) Sritama Nath et al.   TRENDS IN MOLECULAR MEDICINE

Continuing cancer screening later in life: attitudes and intentions among older adults in England

(2013) Christian von Wagner et al.   AGE AND AGEING

Nanobodies: Natural Single-Domain Antibodies

(2013) Serge Muyldermans   Annual Review of Biochemistry

Oncology Meets Immunology: The Cancer-Immunity Cycle

(2013) Daniel S. Chen et al.   IMMUNITY

Influence of tumour micro-environment heterogeneity on therapeutic response

(2013) Melissa R. Junttila et al.   NATURE

Accelerating the design of biomimetic materials by integrating RNA-seq with proteomics and materials science

(2013) Paul A Guerette et al.   NATURE BIOTECHNOLOGY

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

(2013) Teresa Coelho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

(2013) Omid Hamid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

(2013) Stephan A. Grupp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

(2012) Che-Ming Jack Hu et al.   BIOCHEMICAL PHARMACOLOGY

Basis of CTLA-4 function in regulatory and conventional CD4+ T cells

(2012) X. Tai et al.   BLOOD

miR-155 regulates IFN-  production in natural killer cells

(2012) R. Trotta et al.   BLOOD

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses

(2012) Hyun-Il Cho et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor Immunotherapy Directed at PD-1

(2012) Antoni Ribas   NEW ENGLAND JOURNAL OF MEDICINE

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

(2012) SHIGEMASA SUZUKI et al.   ONCOLOGY REPORTS

mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells

(2011) Marie-Luce De Temmerman et al.   BIOMATERIALS

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

(2011) S. A. Rosenberg et al.   CLINICAL CANCER RESEARCH

Toxicity Testing in the 21st Century: A Vision and a Strategy

(2010) Daniel Krewski et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccination against Human Papilloma Virus (HPV): Epidemiological Evidence of HPV in Non-genital Cancers

(2010) Ioannis N. Mammas et al.   PATHOLOGY & ONCOLOGY RESEARCH

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

(2010) M. A. Curran et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity

(2009) Sakulrat Rattanakiat et al.   BIOMATERIALS

Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects

(2009) H.-I. Cho et al.   CANCER RESEARCH

Biodegradable polymeric nanoparticles based drug delivery systems

(2009) Avnesh Kumari et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

The promise and potential pitfalls of chimeric antigen receptors

(2009) Michel Sadelain et al.   CURRENT OPINION IN IMMUNOLOGY

Minireview: Nanoparticles and the Immune System

(2009) Banu S. Zolnik et al.   ENDOCRINOLOGY

Nanoparticle-based targeted drug delivery

(2009) Rajesh Singh et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Progress and prospects: immune responses to viral vectors

(2009) S Nayak et al.   GENE THERAPY

Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells

(2008) M. Bellon et al.   BLOOD

A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer

(2008) Kimberly A. Chianese-Bullock et al.   JOURNAL OF IMMUNOTHERAPY

Interaction of human PD-L1 and B7-1

(2008) Manish J. Butte et al.   MOLECULAR IMMUNOLOGY

Exploring the Immunotoxicity of Carbon Nanotubes

(2008) Yanmei Yu et al.   Nanoscale Research Letters